GlassScriptPhysician profile
Aiden Abidov
NPI 1619181427
$1,445.19
in general payments reported to CMS, 2019-2025
12 companies · $581 in 2025
The $581 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.40 · 2021: $72.64 · 2022: $170 · 2023: $76.00 · 2024: $529 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $546.45 | 2022-2025 | Corevalve Evolut R, Cobalt Dr Mri Surescan, Micra |
| Novo Nordisk INC | $264.13 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $150.16 | 2020-2023 | Lifevest |
| Kestra Medical Technology Services, INC. | $139.34 | 2025 | Assure Wcd |
| Heartflow, INC. | $138.17 | 2024 | |
| Ge Healthcare | $98.86 | 2025 | |
| Pfizer INC. | $78.48 | 2024 | |
| Abbott Laboratories | $29.60 | 2025 | Aveir |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aiden Abidov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.